Had an email sent to me today from somewhere(?) no clue who or why. Anyway it was supposedly an interview with John Sharman.
Unfortunately it read that they have given up on Cancer markers etc.
Going for Xprecia/ Petrackr/ wine testing and now Water testing for Lead
He admirtted very poor market penetration on most of those except XPrecia.
Claimed Petrackr was slow b/c most pet owners already held 70 or 80 test strips from their competitor. Their competitor is also launching a new monitor in the Pet market..
At the end he finished by promising UBI wil be great....one day...be patient.....pretty sad really IMO
Ann: FDA Approval for Xprecia Prime, page-113
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.72M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 14.0¢ | $28.32K | 202.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 264769 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 445 | 1 |
View Market Depth
| Last trade - 15.30pm 24/06/2024 (20 minute delay) ? |
| UBI (ASX) Chart |